Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
204.00
-1.04 (-0.51%)
At close: Dec 5, 2025, 4:00 PM EST
203.05
-0.95 (-0.47%)
After-hours: Dec 5, 2025, 7:51 PM EST
Insmed Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for Insmed stock have an average target of 178.71, with a low estimate of 115 and a high estimate of 256. The average target predicts a decrease of -12.40% from the current stock price of 204.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Insmed stock from 19 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 10 | 10 | 10 |
| Buy | 8 | 8 | 8 | 7 | 7 | 7 |
| Hold | 0 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 19 | 19 | 19 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $196 → $256 | Buy | Maintains | $196 → $256 | +25.49% | Dec 1, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $223 → $231 | Strong Buy | Maintains | $223 → $231 | +13.24% | Nov 20, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $171 → $217 | Buy | Maintains | $171 → $217 | +6.37% | Oct 31, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $196 → $225 | Strong Buy | Maintains | $196 → $225 | +10.29% | Oct 31, 2025 |
| UBS | UBS | Strong Buy Maintains $194 → $223 | Strong Buy | Maintains | $194 → $223 | +9.31% | Oct 31, 2025 |
Financial Forecast
Revenue This Year
520.48M
from 363.71M
Increased by 43.10%
Revenue Next Year
1.19B
from 520.48M
Increased by 128.25%
EPS This Year
-6.22
from -5.57
EPS Next Year
-3.73
from -6.22
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 567.5M | 1.6B | ||||
| Avg | 520.5M | 1.2B | ||||
| Low | 440.0M | 882.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 56.0% | 200.5% | ||||
| Avg | 43.1% | 128.3% | ||||
| Low | 21.0% | 69.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -5.37 | -2.60 | ||||
| Avg | -6.22 | -3.73 | ||||
| Low | -6.62 | -5.25 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.